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TO THE EDITOR
A number of in vivo assays have been
developed to measure the hair follicle–
inducing ability (trichogenicity) of dermal
and epidermal cell populations (revie-
wed by Ohyama et al., 2010; Yang
and Cotsarelis, 2010). In all assays,
dermal cells are considered inducers and
epithelial cells responders during hair
formation. The ‘‘patch assay’’ introduced
by Zheng et al. (2005) has advantages
of simplicity, low cell usage, and of
multiple injections per mouse, and has
been successfully used to measure the
trichogenicity of dermal cells (Ito et al.,
2007; Osada et al., 2007; Young et al.,
2008; Zheng et al., 2010).
Hair follicle neogenesis by follicular
cell implantation is a promising option
for the treatment of hair loss, and it is
believed that the identification and
evaluation of genes responsible for hair
follicle neogenesis are important for the
development of successful cell thera-
pies. Recent studies have demonstrated
that Wnt signaling through the b-catenin
pathway maintains the trichogenicity of
dermal papilla cells (Kishimoto et al.,
2000; Shimizu and Morgan, 2004) and,
thus, suggest that the b-catenin activity
of dermal cells is correlated with tricho-
genicity and that genes transcriptionally
targeted by the b-catenin pathway are
essential for the maintenance of the
trichogenicity of dermal cells.
In this study, we adopted a small
interfering RNA (siRNA)–mediated gene
knockdown approach and a ‘‘patch
assay’’ to confirm that b-catenin signal-
ing in neonatal dermal cells is critical
for the maintenance of trichogenicity.
Subsequently, we found that the OVO
homolog-like 1 (OVOL-1) gene is the
transcriptional target of b-catenin, and
thereafter we evaluated whether the
expression level of OVOL-1 in neonatal
dermal cells is correlated with tricho-
genicity.
For the ‘‘patch assay,’’ dorsal skin was
collected first from C57BL/6 mouse
neonates (P0) and incubated overnight
with 100 mg ml 1 collagenase/dispase
(Roche, Mannheim, Germany) at 4 1C.
The separated dermis and epidermis
were subsequently digested with
0.25% trypsin in phosphate-buffered
saline at 37 1C for 15 minutes, followed
by filtration of the separated epidermal
cells and dermal cells through 70 and
100mm cell strainers, respectively
(Becton Dickinson, Franklin, NJ). Epi-
dermal cells (total isolated cells from
epidermis) were cultured in an EpiLife
Medium (Invitrogen, Carlsbad, CA) in
5% CO2 at 37 1C, and dermal cells
(total isolated cells from dermis) were
cultured in DMEM supplemented with
10% fetal bovine serum (Gibco BRL,
Gaithersburg, MD).
The siRNAs used were purchased
from Bioneer (Daejeon, Korea). Dermal
cells were cultured as above for
24 hours and transfected with either
control siRNA or b-catenin-specific
siRNAs (b-catenin siRNA) at a final
concentration of 10 nM in the presence
of the RNAiMAX reagent (Invitrogen). A
b-catenin siRNA with a significant
knockdown efficiency (Figure 1a) was
selected for further studies. To examine
the effects of b-catenin knockdown
on trichogenicity, cultured dermal cells
were transfected with siRNAs, and 2
days post transfection 2106 cells were
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Figure 1. Impairment of hair follicle neogenesis by the ablation of b-catenin. Relative levels of b-catenin
in neonatal mouse dermal cells transfected with b-catenin small interfering RNA (siRNA) or control siRNA
were measured by real-time PCR. Results are expressed as the means±SDs of four independent
experiments (a). Control siRNA or b-catenin siRNA was introduced into neonatal dermal cells, and the cells
(2 106) were then co-implanted with cultured epidermal cells (2106) into nude mice. Injection sites
were collected 2 weeks later, and total induced hair follicles were counted at each injection site (three sites
per experiment). Data are expressed as means±SDs of three independent experiments performed in
triplicate (b). Representative pictures are shown (c, d). Scale bar¼ 1 mm; *Po0.01.
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resuspended in 100ml of phosphate-buf-
fered saline and co-implanted subcuta-
neously with cultured epidermal cells
(2106) into 7-week-old female Balb/c
nude mice (Orient Bio, Seongnam,
Korea). Mice were killed 2 weeks after
cell implantation, and the implantation
sites were excised and then gross pic-
tures were taken. Hair follicles were
counted by microscopic photography.
As was expected, a significant impair-
ment in hair follicle induction was obse-
rved in b-catenin siRNA–transfected
dermal cells as compared with control
siRNA–transfected cells (Figure 1b–d).
This observation is in line with a recent
report issued by Enshell-Seijffers et al.
(2010), who found that inactivation of
the b-catenin gene within the dermal
papilla of fully developed hair follicles
prevented the normal regeneration
of hair follicles during natural and
induced hair cycles.
To identify genes targeted by the
b-catenin pathway, which are essential
for maintaining the trichogenicity of
dermal cells, we used microarray ana-
lysis. Among the downregulated genes
by b-catenin knockdown, we first
focused on transcription factor genes,
which in turn regulate the expression of
downstream target genes. We observed
that the expression levels of transcription
factors including Twist1, Nfyc, Ovol-1,
Sox5, Tcf7, and Hey2 are decreased
more than 20% by b-catenin knock-
down (Supplementary Table S1 online).
Microarray data have been deposited in
the Gene Expression Omnibus database
(accession number: GSE50525). We
next chose OVOL1 for analysis because
OVOL1 promoter has been proved to
contain a LEF1 binding site and is
activated by LEF1/b-catenin complex
(Li et al., 2002). We then investigated
whether the trichogenicity of neonatal
dermal cells is affected by OVOL1
expression using OVOL1 siRNA with
an overall knockdown efficiency of
44%±2.8 (Figure 2a). Cultured dermal
cells were transfected with either con-
trol siRNA or OVOL1 siRNA for 2 days,
and the cells (3106 cells) were com-
bined with cultured epidermal cells in a
ratio of 1:1 and co-implanted. We found
that OVOL1 siRNA–transfected dermal
cells showed significantly impaired hair
follicle induction (Figure 2b–e). This
result is in line with the finding that
OVOL1 is required for proper develop-
ment of hair (Dai et al., 1998).
To examine the effect of overexpres-
sion of OVOL1 gene expressed in
grafted dermal cells on hair formation
efficiency, dermal cells were cultured as
above and were transduced with either
control lentivirus (Lt-control) or lenti-
virus carrying OVOL1 (Lt-OVOL1) for
48 hours. Thereafter, the dermal cells
(1 106 cells) were mixed with cultured
epidermal cells and grafted as above. As
compared with controls, the OVOL1
mRNA expression was 3.5-fold higher
in mouse dermal cells transduced with
Lt-OVOL1 (Figure 2f). Furthermore, hair
follicle induction was found to be sig-
nificantly increased when mouse dermal
cells transduced with Lt-OVOL1 were
co-implanted with cultured epidermal
cells (Figure 2g–j). Actually, OVOL1-
transduced dermal cells were found to
induce 198±12.1 hair follicles per cyst,
whereas control lentivirus–transduced
cells induced only 14±11.8 hair
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Figure 2. OVO homolog-like 1 (OVOL1) expression level was correlated with the trichogenicity of neonatal dermal cells. The knockdown of OVOL1 expression
in neonatal mouse dermal cells transfected with OVOL1 small interfering RNA (siRNA) or with control siRNA was quantified by real-time PCR (a). Control siRNA
or OVOL1 siRNA was introduced into neonatal dermal cells, and these cells (3 106) were then co-injected into nude mice with cultured epidermal cells
(3 106). The control experiment that has no siRNA transfection (no siRNA) is also included. Data are expressed as the means±SDs of three independent
experiments performed in quadruplicate (b) and representative pictures are shown (c–e). Neonatal dermal cells were transduced with control lentivirus (Lt-control)
or lentivirus carrying OVOL1 (Lt-OVOL1) for 48 hours, and the mRNA levels of OVOL1 were quantified by real-time PCR. Results are expressed as the
means±SDs of three independent experiments performed in triplicate (f). Lentivirus-transduced dermal cells (1106) were co-injected into nude mice with
cultured epidermal cells (1 106). The control experiment that has no lentivirus infection (no lentivirus) is also included. Data are expressed as the means±SDs of
three independent experiments performed in triplicate (g). Representative pictures are shown (h–j). Scale bar¼ 1 mm; *Po0.01.
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follicles per cyst. The control experi-
ment that has no lentivirus infection (no
lentivirus) induced 37±18.9 hair folli-
cles per cyst.
In summary, we found that OVOL1 of
mouse neonatal dermal cells has a critical
role in hair follicle neogenesis, which has
not been previously reported. In view of
the fact that OVOL1 is a transcription
factor, genes targeted by OVOL1 are
believed to be involved in hair neogenesis.
All animal experiments were con-
ducted in accordance with guidelines
and approval of the institutional animal
care and use committee at Kyungpook
National University.
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TO THE EDITOR
The incidence of cutaneous B-cell
lymphoma (CBCL) has been increasing
over decades, with a recent (2001–2005)
overall annual age-adjusted incidence
rate of 3.1 cases per million persons
(Bradford et al., 2009). We sought to
measure incidence trend changes in
CBCL using population-based data.
Incidence data were derived from the
nine original registries of the Surveil-
lance, Epidemiology, and End Results
(SEERs) program of the National Cancer
Institute from 1973 to 2010. Cases of
CBCL were defined according to the
International Classification of Diseases
for Oncology, third edition (ICD-O-3).
The primary site of involvement was
coded for skin (44.0–44.9). CBCL diag-
noses were coded as the following: small
B-lymphocytic non-Hodgkin’s lymphoma
(NHL), nitric oxide synthase (NOS;
9670), lymphoplasmacytic NHL (9671),
mantle cell lymphoma (9673), diffuse
large B-cell NHL (9680), immunoblastic
diffuse large B-cell NHL (9684), Burkitt
lymphoma NOS (9687), follicular lym-
phoma NOS (9690), follicular lym-
phoma grades 1–3 (9691, 9695, 9698),
and marginal-zone B-cell lymphoma
NOS (9699). Institutional review board
approval was not required.
Data were analyzed using SEER*Stat
version 7.0.5 of the National Cancer
Institute and Stata SE version 8
(StataCorp, College Station, TX). Inci-
dence rates were adjusted according to
age using the 2000 US standard popula-
tion and are reported per million per-
sons. Trends for CBCL were analyzed
using the JoinPoint regression program
4.0.1 (National Cancer Institute). A join-
point year refers to the year in which a
statistically significant change in inci-
dence trend is found.
CBCL incidence has steadily
increased from 0.65 per million persons
between 1973 and 1980 to an average
annual rate of 3.70 between 2001 and
2005 and to 3.92 between 2006 and
2010, Po0.001 (Table 1). This increase
was statistically significant in all tested
subgroups including race, age, and gen-
der and registry.
Despite an overall increase in CBCL
incidence over the past few decades,Accepted article preview online 13 September 2013; published online 17 October 2013
Abbreviations: APC, annual percentage change; CBCL, cutaneous B-cell lymphoma; CI, confidence
interval; CL, cutaneous lymphoma; NHL, non-Hodgkin’s lymphoma
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